Gleason Score News and Research

RSS
Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

Predicting bone metastases type in prostate cancer using MRI

Predicting bone metastases type in prostate cancer using MRI

What is the relative burden of oncologic and nononcologic mortality among long-term survivors of cancer in the US?

What is the relative burden of oncologic and nononcologic mortality among long-term survivors of cancer in the US?

Enhanced prediction of prostate cancer recurrence using machine learning model

Enhanced prediction of prostate cancer recurrence using machine learning model

Clinical trial confirms the safety, efficacy of shortened radiation therapy for high-risk prostate cancer patients

Clinical trial confirms the safety, efficacy of shortened radiation therapy for high-risk prostate cancer patients

New model predicts which patients will gain most from PSMA PET scan

New model predicts which patients will gain most from PSMA PET scan

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

Genetic alterations linked to high incidence of prostate cancer in African American men

Genetic alterations linked to high incidence of prostate cancer in African American men

New eco-evolutionary mathematical model can predict prostate cancer aggressiveness

New eco-evolutionary mathematical model can predict prostate cancer aggressiveness

Study demonstrates accuracy of AI system in diagnosing prostate cancer

Study demonstrates accuracy of AI system in diagnosing prostate cancer

New AI system determines aggressiveness of prostate cancer better than most pathologists

New AI system determines aggressiveness of prostate cancer better than most pathologists

AI identifies previously unknown features relevant to cancer prognosis

AI identifies previously unknown features relevant to cancer prognosis

TSU researchers develop new approach to diagnose adenocarcinoma

TSU researchers develop new approach to diagnose adenocarcinoma

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.